Chinese Multiple Dose Escalation (MDE) High Dose Study

Summary

A Phase 1 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Cotadutide in Overweight/Obese Subjects with Chinese ancestry with Type 2 Diabetes Mellitus

Timeline

Start

2022-02-25

Primary completion

2022-12-12

Completion

2022-12-12

Drugs

Indications